In studies of patients with melanoma, Fourcade and colleagues demonstrated that CD4+CD25− T cells and Foxp3+CD4+ T cells could recognize the same peptide and moreover, clonotypic analyses of these cells revealed a common T cell receptor (TCR) Vβ usage (75). This evidence concerns the gene CD4 and melanoma.